Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | PRKDC | P78527 | 2/20 | 0.36 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.32 |
| ▸ | F9 | P00740 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22097043 | 0.94 | CYP1A1 (0.36) | ALOX5CYP1A1CYP1B1CYP1A2LIMK1 | |
| SCHEMBL22097026 | 0.94 | CYP1A1 (0.36) | ALOX5CYP1A1CYP1B1CYP1A2LIMK1 | |
| SCHEMBL22097230 | 0.86 | CYP1A1 (0.36) | CYP1A1CYP1B1CYP1A2LIMK1MEN1 | |
| SCHEMBL22096958 | 0.86 | CYP1A1 (0.36) | CYP1A1CYP1B1CYP1A2LIMK1MEN1 | |
| SCHEMBL22880015 | 0.86 | CYP1A1 (0.38) | ALOX5CYP1A1CYP1B1CYP1A2LIMK1 | |
| SCHEMBL22880121 | 0.85 | CYP1A1 (0.38) | ALOX5CYP1A1CYP1B1CYP1A2LIMK1 | |
| SCHEMBL22880492 | 0.85 | ALOX5 (0.36) | ALOX5PRKDCCYP1A1CYP1B1CYP1A2 | |
| SCHEMBL21186838 | 0.84 | CYP1A1 (0.33) | ALOX5CYP1A1CYP1B1CYP1A2LIMK1 | |
| SCHEMBL24628506 | 0.84 | CYP1A1 (0.34) | ALOX5CYP1A1CYP1B1CYP1A2LIMK1 | |
| SCHEMBL22880245 | 0.84 | CYP1A1 (0.39) | ALOX5PRKDCCYP1A1CYP1B1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11236075-B2 | Organic compound and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-02-01 | — | — | US | disclosed |
| US-20200190065-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11236075-B2 | Organic compound and organic electroluminescence device using the same | ICMT, OR10J3, PIEZO1 | ALOX5 846/4885PRKDC 3713/4885DNPH1 1123/4885 |
| US-20200190065-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | ICMT, OR10J3, PIEZO1 | ALOX5 846/4885PRKDC 3713/4885DNPH1 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.